Case Studies in the Management of Metastatic Breast Cancer with Eribulin

Lignende værker

• Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies
  af: O’Shaughnessy, Joyce, et al.
  Udgivet: (2015)
• Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
  af: Lee Schwartzberg, et al.
  Udgivet: (2019-06-01)
• Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
  af: Schwartzberg, Lee, et al.
  Udgivet: (2019)
• Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer
  af: McIntyre, Kristi, et al.
  Udgivet: (2014)
• Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
  af: Arpino, Grazia, et al.
  Udgivet: (2015)